| HOME >> BIOLOGY >> TECHNOLOGY |
Capital and statutory reserves 3,025,794 3,025,794
Total stockholders' equity 44,395,267 23,910,007
Total liabilities and stockholders'
equity $ 93,791,526 $ 44,579,844
CHINA-BIOTICS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
(Audited, amounts expressed in US Dollars)
FOR THE YEARS ENDED MARCH 31, 2008 AND 2007
CASH FLOWS FROM OPERATING ACTIVITIES 2008 2007
Net income 17,542,244 $10,904,986
Adjustment for:
Gain on disposal of plant and
equipment -- (14,793)
Depreciation 999,148 493,472
Change in fair value of convertible
notes (3,366,000) --
(Increase)/Decrease in restricted
cash -- 748,742
(Increase)/Decrease in accounts
receivable 2,261,918 (2,881,034)
(Increase)/Decrease in inventories (154,189) 65,303
(Increase)/Decrease in prepayment (1,418,658) (352,923)
(Increase)/Decrease in other
receivables 2,732
Increase/(Decrease) in accounts
payable 1,036,521 (451,305)
Increase in income tax and surcharge
tax payable 5,008,143 4,186,868
Income tax paid (2,969,765) (2,373,846)
Increase/(Decrease) in other payables
and accruals, and value added tax
payable
'/>"/>
| SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved |